These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12937311)

  • 1. Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial.
    Davies SJ; Woodrow G; Donovan K; Plum J; Williams P; Johansson AC; Bosselmann HP; Heimbürger O; Simonsen O; Davenport A; Tranaeus A; Divino Filho JC
    J Am Soc Nephrol; 2003 Sep; 14(9):2338-44. PubMed ID: 12937311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study.
    Konings CJ; Kooman JP; Schonck M; Gladziwa U; Wirtz J; van den Wall Bake AW; Gerlag PG; Hoorntje SJ; Wolters J; van der Sande FM; Leunissen KM
    Kidney Int; 2003 Apr; 63(4):1556-63. PubMed ID: 12631373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of a favourable response to icodextrin in peritoneal dialysis patients with ultrafiltration failure.
    Wiggins KJ; Rumpsfeld M; Blizzard S; Johnson DW
    Nephrology (Carlton); 2005 Feb; 10(1):33-6. PubMed ID: 15705179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid.
    Lin A; Qian J; Li X; Yu X; Liu W; Sun Y; Chen N; Mei C;
    Clin J Am Soc Nephrol; 2009 Nov; 4(11):1799-804. PubMed ID: 19808224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone.
    Jenkins SB; Wilkie ME
    Perit Dial Int; 2003; 23(5):475-80. PubMed ID: 14604201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis.
    Plum J; Gentile S; Verger C; Brunkhorst R; Bahner U; Faller B; Peeters J; Freida P; Struijk DG; Krediet RT; Grabensee B; Tranaeus A; Filho JC
    Am J Kidney Dis; 2002 Apr; 39(4):862-71. PubMed ID: 11920355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Icodextrin increases technique survival rate in peritoneal dialysis patients with diabetic nephropathy by improving body fluid management: a randomized controlled trial.
    Takatori Y; Akagi S; Sugiyama H; Inoue J; Kojo S; Morinaga H; Nakao K; Wada J; Makino H
    Clin J Am Soc Nephrol; 2011 Jun; 6(6):1337-44. PubMed ID: 21493740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials.
    Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GF; Wiggins KJ
    Nephrol Dial Transplant; 2013 Jul; 28(7):1899-907. PubMed ID: 23493329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials.
    Qi H; Xu C; Yan H; Ma J
    Perit Dial Int; 2011; 31(2):179-88. PubMed ID: 21119069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload.
    Johnson DW; Arndt M; O'Shea A; Watt R; Hamilton J; Vincent K
    BMC Nephrol; 2001 Dec; 2():2. PubMed ID: 11737871
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell.
    Freida P; Galach M; Divino Filho JC; Werynski A; Lindholm B
    Perit Dial Int; 2007; 27(3):267-76. PubMed ID: 17468474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration.
    Finkelstein F; Healy H; Abu-Alfa A; Ahmad S; Brown F; Gehr T; Nash K; Sorkin M; Mujais S
    J Am Soc Nephrol; 2005 Feb; 16(2):546-54. PubMed ID: 15625070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of icodextrin in automated peritoneal dialysis on blood pressure and bioelectrical impedance analysis.
    Woodrow G; Oldroyd B; Stables G; Gibson J; Turney JH; Brownjohn AM
    Nephrol Dial Transplant; 2000 Jun; 15(6):862-6. PubMed ID: 10831642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced ultrafiltration using 7.5% icodextrin/1.36% glucose combination dialysate: a pilot study.
    Dallas F; Jenkins SB; Wilkie ME
    Perit Dial Int; 2004; 24(6):542-6. PubMed ID: 15559483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
    Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
    Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Icodextrin Versus Glucose Solutions for the Once-Daily Long Dwell in Peritoneal Dialysis: An Enriched Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Goossen K; Becker M; Marshall MR; Bühn S; Breuing J; Firanek CA; Hess S; Nariai H; Sloand JA; Yao Q; Chang TI; Chen J; Paniagua R; Takatori Y; Wada J; Pieper D
    Am J Kidney Dis; 2020 Jun; 75(6):830-846. PubMed ID: 32033860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of a dialysis solution with icodextrin on ultrafiltration and selected metabolic parameters in patients treated with peritoneal dialysis].
    Opatrná S; Racek J; Stehlík P; Senft V; Sefrna F; Topolcan O; Opatrný K
    Cas Lek Cesk; 2002 May; 141(9):281-5. PubMed ID: 12061197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Icodextrin Solution on the Preservation of Residual Renal Function in Peritoneal Dialysis Patients: A Randomized Controlled Study.
    Chang TI; Ryu DR; Yoo TH; Kim HJ; Kang EW; Kim H; Chang JH; Kim DK; Moon SJ; Yoon SY; Han SH;
    Medicine (Baltimore); 2016 Mar; 95(13):e2991. PubMed ID: 27043667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Echocardiographic, electrocardiographic and blood pressure changes induced by icodextrin solution in diabetic patients on peritoneal dialysis.
    Paniagua R; Orihuela O; Ventura MD; Avila-Díaz M; Cisneros A; Vicenté-Martínez M; Furlong MD; García-González Z; Villanueva D; Prado-Uribe MD; Alcántara G; Amato D
    Kidney Int Suppl; 2008 Apr; (108):S125-30. PubMed ID: 18379535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Icodextrin: What arguments for and against its use as an osmotic agent in peritoneal dialysis].
    Savenkoff B; Flechon-Meibody F; Goffin É
    Nephrol Ther; 2018 Jun; 14(4):201-206. PubMed ID: 29291942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.